44 completed, 6 unknown, 3 terminated. 30 Phase 3, 11 Phase 4, 7 Phase 2, 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 30 | Completed 29, Unknown 1 |
| Phase 4 | 11 | Completed 6, Unknown 3, Terminated 2 |
| Phase 2 | 7 | Completed 5, Terminated 1, Unknown 1 |
| Not applicable | 3 | Completed 3 |
Follow Symbicort: new trials by email Literature Review of Symbicort trials Research Report on Symbicort
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| U-LABA/ICS Effects on Exercise Performance, Formoterol Symbicort, Formoterol, Placebo - Exercise Performance | Not applicable | Completed | Morten Hostrup, PhD | 20 | 2024-01-05 | 2024-08-13 |
| Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma. CMAB007, Symbicort, Seretide - Asthma, Allergic | Phase 3 | Completed | Shanghai Biomabs Pharmaceutical Co., Ltd. | 393 | 2018-05-09 | 2021-10-11 |
| Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis Symbicort, Spiriva - COPD, Bronchiectasis | Phase 4 | Unknown | Shanghai Pulmonary Hospital, Shanghai, China | 90 | 2017-09-15 | 2019-08-01 |
| Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients Budesonide/Formoterol fumarate dihydrate, Symbicort, Placebo - Asthma | Phase 3 | Completed | Kindeva Drug Delivery | 1762 | 2016-12-29 | 2022-08-24 |
| Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler® BGF MDI (PT010), GFF MDI (PT003), BFF MDI (PT009) - COPD | Phase 3 | Completed | Pearl Therapeutics, Inc. | 416 | 2016-08-09 | 2020-05-13 |
| Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma Placebo, Dupilumab SAR231893/REGN668, fluticasone propionate and salmeterol - Asthma | Phase 2 | Completed | Sanofi | 42 | 2016-01-27 | 2022-04-04 |
| Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients budesonide 160μg/formoterol 4.5μg - Bronchial Asthma | Phase 4 | Unknown | Zhujiang Hospital | 30 | 2015-09-01 | 2016-10-17 |
| Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics methacholine, adenosine monophosphate, leukotriene D4 - Asthma | Phase 4 | Unknown | Zhujiang Hospital | 80 | 2015-04-01 | 2015-10-16 |
| A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota Fluticasone group, Budesonide group, Formoterol group - Chronic Obstructive Pulmonary Disease | Phase 2 | Unknown | University of British Columbia | 69 | 2015-02-01 | 2020-03-30 |
| Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease Symbicort, Formoterol turbohaler, Placebo for Symbicort pMDI - COPD Patients | Phase 3 | Completed | AstraZeneca | 2026 | 2014-06-27 | 2017-11-07 |
| Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids Treatment with any inhaled corticosteroid, Treatment with any intranasal glucocorticoid - ASTHMA, ALLERGIC RHINITIS | Unknown | Meir Medical Center | 60 | 2013-05-01 | 2014-03-11 | |
| Effects of Symbicort on the Ventilatory Kinematics Budesonide, Symbicort - Chronic Obstructive Lung Disease | Phase 4 | Terminated | Columbia University | 9 | 2012-03-01 | 2016-09-02 |
| New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day Symbicort, Budesonide - Asthma | Phase 3 | Completed | AstraZeneca | 214 | 2011-11-01 | 2014-03-11 |
| Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant Prednisone, Azithromycin, Montelukast - Respiratory Tract Infections, Bronchiolitis Obliterans | Phase 2 | Terminated | Maisonneuve-Rosemont Hospital | 12 | 2011-09-01 | 2021-10-20 |
| Effect of Symbicort on Sleep Quality in Patients With Emphysema Budesonide/formoterol, Placebo - Emphysema, Poor Sleep Quality | Phase 3 | Unknown | Temple University | 40 | 2011-03-01 | 2012-12-07 |
| Sub-Sensitivity to Long-Acting Bronchodilators (LABA) fluticasone propionate and salmeterol, budesonide and formoterol - Asthma | Not applicable | Completed | National Jewish Health | 20 | 2010-03-01 | 2026-07-06 |
| Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma Budesonide/Formoterol, Budesonide - Exercise Induced Asthma | Phase 4 | Terminated | Boston Children's Hospital | 6 | 2010-02-01 | 2021-07-07 |
| Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations Symbicort - Asthma | Not applicable | Completed | Stanford University | 10 | 2009-09-01 | 2017-08-18 |
| Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus) pMDI budesonide/formotrol 160/4.5 is in group 1, Symbicort 160/4.5 plus Aerochamber Plus included in group 2 - Asthma | Phase 4 | Completed | Western Sky Medical Research | 16 | 2009-07-01 | 2020-08-13 |
| Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia Symbicort (Budesonide/Formoterol) - Asthma | Phase 4 | Completed | AstraZeneca | 862 | 2009-07-01 | 2012-01-16 |
Showing 20 of 53. Sign in to see all of them.
Asthma (37) · Pulmonary Disease, Chronic Obstructive (11) · Bronchiolitis Obliterans (2) · Asthma, Exercise-Induced (1) · Bronchiectasis (1) · Cough-Variant Asthma (1) · Cryptogenic Organizing Pneumonia (1) · Emergencies (1) · Emphysema (1) · Hypersensitivity (1) · Lung Diseases, Interstitial (1) · Lung Diseases, Obstructive (1) · Lymphoma, Follicular (1) · Respiratory Tract Infections (1) · Rhinitis, Allergic (1)
AstraZeneca (33) · Zhujiang Hospital (2) · ALK-Abelló A/S (1) · Assistance Publique - Hôpitaux de Paris (1) · Boston Children's Hospital (1) · Columbia University (1) · Hull University Teaching Hospitals NHS Trust (1) · Kindeva Drug Delivery (1) · Maisonneuve-Rosemont Hospital (1) · Meir Medical Center (1) · Morten Hostrup, PhD (1) · National Jewish Health (1) · Pearl Therapeutics, Inc. (1) · Sanofi (1) · Shanghai Biomabs Pharmaceutical Co., Ltd. (1)
United States (13) · China (6) · Canada (5) · Germany (5) · Sweden (5) · Denmark (4) · France (4) · Spain (4) · United Kingdom (4) · Japan (3) · Argentina (2) · Bulgaria (2) · Chile (2) · Croatia (2) · Czechia (2)
Catherine Bonuccelli (12) · Tomas LG Andersson, MD (2) · Alyn H Morice, Professor (1) · Anan Marija Gjurovic (1) · Brian Rowe, MD (1) · Christer Hultquist, MD (1) · Don Sin, MD (1) · Eilon Krashin, MD (1) · Elizabeth F Krakow, MD,CM, FRCPC (1) · Gary T Ferguson, MD (1)
PMID 22329608, PMID 19995138, PMID 36472162, PMID 17296644, PMID 17905575, PMID 18972276, PMID 19228428, PMID 19663129, PMID 19769705, PMID 19878590, PMID 20167145, PMID 20170333, PMID 20509942, PMID 20713475, PMID 22932169, PMID 23176189, PMID 23557023, PMID 24267370, PMID 24524222, PMID 24671923, PMID 24872685, PMID 24952426, PMID 25596138, PMID 26831844, PMID 27039236, PMID 34464242, PMID 34610114, PMID 35740433, PMID 35815359, PMID 41345745
2015 (1)